Shalby Share News - Latest Updates, Live News & More

Latest news about Shalby

Shalby Limited Reports Mixed Q2 FY26 Results: Revenue Up 5.5%, PAT Surges 200% Amid Challenges Nov 20, 2025

Shalby Limited announced Q2 FY26 results with consolidated revenue up 5.5% to INR 289.00 crores and PAT surging 200% to INR 7.30 crores. EBITDA improved by 15.8% to INR 46.10 crores. Despite revenue growth, the company faced challenges with occupancy rate at 48% and declining patient footfall. Shalby International Hospital in Gurgaon saw a 22.7% revenue decline. The company outlined strategic initiatives including rebranding, leadership restructuring, and onboarding new clinical talent. Future plans include expanding robotic surgeries and adding cancer treatment facilities.

Shalby Limited Reports Strong Q2 FY26 Performance with 146% Jump in Net Profit Nov 14, 2025

Shalby Limited Issues ₹716 Crore Corporate Guarantee for Subsidiary's Credit Facilities Nov 08, 2025

Shalby Limited CFO Amit Pathak Steps Down, Replacement to be Announced Soon Oct 24, 2025

Shalby Limited's Promoter Shah Family Trust Boosts Stake with Rs 1.44 Crore Share Purchase Sep 20, 2025

More news about Shalby

28Aug 25

Shalby Limited Issues ₹25 Crore Corporate Guarantee for Subsidiary's Equipment Lease

Shalby Limited has issued a corporate guarantee of up to ₹25 crore for its wholly-owned subsidiary, Shalby Medtech Limited (SMTL). The guarantee is in favor of Easy Assets Private Limited and Aditya Birla Capital Limited for lease rental facilities granted to SMTL. The transaction is expected to have no financial or operational impact on Shalby Limited as a listed entity. Promoters and promoter groups have no interest in this transaction. The disclosure was made under Regulation 30 of SEBI regulations.

25Aug 25

Shalby Ltd. Partners with BSDU to Launch Healthcare Education Programs

Shalby Ltd. has signed an MoU with Bhartiya Skill Development University in Jaipur to offer B.Voc. programs in Allied Health and Paramedic Skills. The partnership will introduce three programs: Medical Laboratory Technology, Operation Theatre & Anesthesia Technology, and Medical Radiology Imaging Technology. The programs will follow a Swiss Dual Learning Model, combining clinical training at Shalby Hospitals with academic learning at BSDU. Top-performing students will receive preferential placement opportunities within the Shalby Hospital network. This collaboration aims to address the increasing demand for qualified healthcare professionals.

19Aug 25

Shalby Limited Reports Mixed Q1 Results with Revenue Crossing INR 300 Crores

Shalby Limited achieved record consolidated revenue of INR 303 crores in Q1, up 12.30% QoQ and 5.10% YoY. EBITDA rose 85.60% QoQ to INR 48.50 crores but declined 11.60% YoY. PAT increased 163% QoQ to INR 7.70 crores, down 47% YoY. Hospital occupancy dropped to 45%, while ARPOB increased 5.3%. The implant business saw 74.2% revenue growth. Management targets 12-15% consolidated revenue growth for FY2026 and aims to improve occupancy to over 50%.

13Aug 25

Shalby Limited Reports Mixed Q1 Results with Revenue Growth and Profit Decline

Shalby Limited's Q1 financial results show a 6.3% year-over-year revenue increase to ₹2,964.26 crore, driven by healthcare services. However, net profit declined 47.9% to ₹76.78 crore. Healthcare services segment contributed ₹2,683.63 crore with a profit of ₹325.67 crore, while the implant manufacturing segment reported a loss. Over 9,000 surgeries were performed, with a slight decrease in inpatient count. ARPOB increased by 5.3% to ₹45,673, but occupancy rate dropped to 45%. The company's consolidated net debt stood at ₹3,025 crore, with a 6.8% ROCE for the quarter.

27Jul 25

Shalby Hospitals Pioneers World's First Fully Autonomous Robotic Joint Replacement Surgery

Shalby Limited, operating as Shalby Hospitals, has successfully conducted the world's first fully autonomous robotic joint replacement surgery. The procedure utilized a state-of-the-art 7-axis robotic arm, the only saw-based system of its kind globally. This technological advancement promises improved surgical accuracy, enhanced bone cut precision, and minimally invasive procedures. Shalby, founded by Dr. Vikram Shah, has performed over 150,000 joint replacement procedures and holds a 15% market share in India's organized joint replacement market. The company operates 11 multispecialty hospitals and 5 orthopedic centers of excellence, with over 2,200 hospital beds.

08Jul 25

Shalby Partners with SVVV Indore to Launch Healthcare Management Programs

Shalby Ltd has announced a strategic partnership with Shri Vaishnav Vidyapeeth Vishwavidyalaya (SVVV) in Indore to introduce healthcare management programs. The collaboration aims to bridge the gap between academic education and practical healthcare management skills. The partnership will focus on introducing specialized healthcare management programs, enhancing skills of future healthcare professionals, and providing industry-tailored education. This initiative is expected to contribute to skill development, foster industry-academia collaboration, and address the growing demand for skilled professionals in healthcare management.

20Jun 25

Shalby's Unit Secures International Accreditation from AACI America LLC

A unit of Shalby Limited has been accredited by AACI America LLC, an internationally recognized accrediting body. This accreditation signifies the unit's adherence to high-quality standards in healthcare delivery, including patient safety, quality of care, and operational efficiency. The recognition is expected to enhance Shalby's reputation, potentially attract international patients, and strengthen its position in the competitive healthcare market.

30May 25

Shalby Ltd Reports Widening Q4 Losses and Declining Margins

Shalby Ltd, a healthcare provider, released Q4 financial results showing increased losses and decreased revenue. The company reported a loss of ₹11.82 crore, up from ₹5.75 crore in Q3. Revenue fell to ₹265.00 crore from ₹276.00 crore. EBITDA decreased to ₹20.80 crore with margins narrowing to 7.90%. For the full fiscal year, revenue increased to ₹1,087.00 crore, but the company reported an annual loss of ₹0.70 crore. Following the announcement, Shalby's shares declined by 5.40%.

29May 25

Shalby Reports Mixed Q4 Results: Net Loss Narrows, Revenue Grows, but EBITDA Declines

Shalby Ltd. reported a 6.56% year-over-year revenue increase to ₹260.00 crore in Q4. Net loss narrowed to ₹11.00 crore from ₹16.60 crore last year. However, EBITDA declined 46.27% to ₹20.90 crore, with EBITDA margin falling to 7.89% from 15.93%. Sequential performance showed increased losses compared to the previous quarter.

25Mar 25

Shalby Ltd Terminates Franchise Agreement with Divine Super Specialty Hospital in Ranchi

Shalby Limited has terminated its franchise agreement with Divine Super Specialty Hospital Private Limited in Ranchi due to multiple breaches of terms and conditions. The termination notice was issued on March 25, 2025. Shalby asserts that this decision will not significantly impact its financial position. Separately, the company announced a trading window closure for insiders from April 1, 2025, until 48 hours after the declaration of the Audited Financial Results for Q4 and FY 2024-25.